Beckwith-Wiedemann syndrome

Disease Description (Causes and Symptoms)

• Definition and cause: Graft-versus-host disease (GVHD) is an immune-mediated complication that occurs when donor T lymphocytes contained in allogeneic hematopoietic stem cell (bone marrow) transplants or transfused blood components recognize the host (recipient)'s tissues as non-self and attack them.
• Pathophysiology: Donor T cells recognize host antigens (such as HLA) → inflammatory cytokine secretion and immune-cell-mediated tissue damage → mainly affecting the skin, liver, and gastrointestinal tract. It is classified as acute (usually ≤100 days after transplantation) or chronic (>100 days), and the clinical features may overlap.
• Main symptoms: Skin rash (erythema, epidermal-dermal separation and blisters), abnormal liver function (jaundice and elevated liver enzymes), gastrointestinal symptoms (nausea, vomiting, loss of appetite, abdominal pain, and diarrhea), generalized weakness, fever, and increased susceptibility to infection. Chronic GVHD may cause chronic organ damage such as skin sclerosis, dry eyes and mouth, and lung involvement (decreased pulmonary function and bronchiolitis obliterans).

Treatment Methods

• Prevention (after transplantation): Maximize HLA matching, donor selection, consideration of the hematopoietic stem cell source (bone marrow vs. peripheral blood or cord blood), prophylaxis (e.g., cyclosporine or tacrolimus + methotrexate or poseuporiaeoseu, etc.), removal of T cells from the graft, or post-transplant cyclophosphamide (in some protocols).
• First-line treatment for acute GVHD: Systemic steroids (e.g., prednisolone 1–2 mg/kg/day) are the standard initial regimen.
• Treatment for steroid-refractory or steroid-dependent disease (requires prompt specialist assessment):
  • Addition or substitution of immunosuppressants: cyclosporine, tacrolimus, mycophenolate mofetil, sirolimus, antithymocyte globulin (ATG), etc.
  • Targeted therapies/new drugs: JAK inhibitors (ruxolitinib — approved for steroid-refractory acute and chronic GVHD), BTK inhibitors (ibrutinib — approved as second-line treatment for chronic GVHD), and other investigational drugs.
  • Physical and mechanical treatment: extracorporeal photopheresis — used for chronic cutaneous and sclerodermatous GVHD.
• Symptom-specific topical treatment and supportive care: Topical steroids for the skin, treatment for dry mouth and eyes (artificial tears and topical steroids), nutritional support (management of malabsorption in cases of severe diarrhea), and electrolyte and fluid replacement.
• Infection prevention and management: Antiviral treatment (e.g., CMV monitoring and specific treatment), and prophylaxis against fungal, bacterial, and PCP (Pneumocystis jirovecii) infections.
• Lifestyle management and precautions: Manage the risk of infection caused by immunosuppression (contact the healthcare provider immediately if fever develops), coordinate the timing of vaccinations (live vaccines are contraindicated), maintain skin and oral hygiene, and stop smoking and maintain adequate nutrition.

Outpatient Visit Checklist (Including Preparation and Example Questions)

• Items to bring (recommended)
  • List of medications currently being taken (including immunosuppressants, antibiotics, other prescriptions, and OTC medications) and a medication schedule
  • Transplant-related records: transplant date, donor information (whether HLA matching was performed), transplant type (bone marrow/peripheral blood/cord blood), and a summary of pre-transplant conditioning (depletion therapy)
  • Recent test results: CBC, liver function tests (ALT/AST, bilirubin), electrolytes, kidney function, CMV PCR, etc.
  • Symptom diary: photographs of rashes (with a scale if possible), number and volume of diarrheal stools, weight changes, and records of changes such as fever or shortness of breath
  • Allergy and past infection history, and vaccination records
• Show at the outpatient visit: Photographs of skin lesions, recent hospital admission records, and copies of prescriptions and medical records
• Example questions for the outpatient visit (write them down beforehand)
  • When the symptoms started, how they have progressed (improved or worsened), and factors that trigger worsening (medications, exposure to infections, etc.)
  • Which infection-prevention medications are currently being taken and the results of recent viral tests such as CMV

General Example Questions to Ask the Doctor

• How do you distinguish whether this condition is acute or chronic? What is the prognosis?
• What are the major side effects of the immunosuppressant you plan to prescribe, and which tests (blood, liver, kidney, etc.) need to be monitored?
• What additional tests should be performed to prevent infection, and what should I do if I develop a fever?
• When should I receive vaccinations, and which vaccines should I receive (including whether live vaccines are allowed)?
• What precautions should I take in daily life (exercise, work, contact with family, and travel)?

Examples of Disease-Specific Questions

• If there is no response to steroid treatment, which of the next-step treatment options (e.g., ruxolitinib, ibrutinib, extracorporeal photopheresis, etc.) would you recommend, and what are the expected benefits and risks?
• The skin rash is severe; based on which results among the skin biopsy, imaging, and blood tests do you determine the intensity of treatment?